Additionally, assessing for CIN in serrated or hyperplastic polyposis syndrome (SPS, HPS) samples could shed light onto the pathway of neoplastic progression for serrated polyposis syndrome and HPS and KRAS mutations have been implicated in both [37]. The gene discussed is KRAS; the disease is hyperplastic polyposis syndrome.